clinical trial · NCT07362030
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
Guangdong Raynovent Biotech Co., Ltd·phase1·active not recruiting·n = 32
ObesityRAY1225atorvastatin calcium tabletMetformin TabletsWarfarin Sodium TabletsDigoxin Tablets
brief summary
The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and
started
Apr 14, 2025
primary completion
Dec 27, 2025
completion
Mar 30, 2026
last updated
Jan 23, 2026
official title
A Open-Label, Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol